1[1]Buyse M, Zeleniuch-Jacquotto A, Chalmers TC. Adjuvant therapy of colorectal cancer: Why we still don't know. JAMA, 1988, 259:3571～3578.
2[2]Higgens GA, Amadeo JH, Mc Elhinney J, et al. Efficacy of prolonged intermittent therapy withcombined 5-fluorouracil and methyl-CCNU following resection for carcinoma of the large bowel. Cancer, 1984, 53:1～8.
3[3]Wolmark N, Fisher B, Rockette H, et al. Postoperative adjuvant chemotherapy or BCG for colon cancer: Results from NASBP protocol C-01. J Natl Cancer Inst, 1988, 80:30～36.
4[4]Moertel CG, Fleming TR, Mac Donald JS, et al. Levamisole and fluorouracil for adjuvamtherapy of resected colon carcinoma. N Engl J Med, 1990, 322:352～358.
5[5]Connell MJ, Mailliard JA, Kahn MJ, et al. Controlled trial of fluorouracil and low doseleucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. J Clin Oncol, 1997, 15:246～250.
6[6]Zaniboni A, labianca R, Marsoni S, et al. A randomized triai of adjuvant 5-fluoruracil andnic acid administered to patients with colon carcinomaf: Long term results and evaluation of the indicators of health-related quality of life. Cancer, 1998, 82:2135～2144.
7[7]Wolmark N, Rockette H, Mamounas EP, et al. The relative efficacy of 5-Fu and leucovorin(Fu-LV), 5-Fu and levamisole(Fu-Lev) and 5-Fu and leucovorin and levamisole(Fu-LV-Lev) in patients with Duke's B and C carcinoma of the colon f first report of NSABP C-04 [abstract 460].Proceedings of the American Society of Clinical Oncology, 1996, 15:205.
8[8]Haller DG, Catalano PJ, Macdonald JS, et al. Fluorouracil(Fu) leu-covorin(LV) and levamisole(Lev) adjuvont therapy for colon cancer: Five-year final report of INT-089 [abstract 982]. Proceedings of the American Society of Clinical Oncology, 1998, 17:256.
9[9]O'Connell MJ, Laurie JA, Kahn M, et al. Prospectively randomized trial of postoperative adjuvant chemotherapy in patieots with high risk colon cancer. J Clin Oncol, 1998, 16:295～300.
10[10] Mamounas EP, Rockette H, Jones J, et al. Comparative efficacy of adjuvant chemotherapy in patients with Ducke's B versus Dicue's C colon cancer: Results from four NSABP adjuvant studies(C-01, C-02, C-03, C-04) [abstract 461]. Proceedings of the American Society of Clinical Oncology, 1996, 15:205.
10JIAN D L, SHENG H C,CHIH L L, et al. Inhibition of melanoma growth and metastasis by combination with(- )Epigallocatechin3-Gallate and dacarbazine in mice[J]. J Cellular Biochem,2001,83:631.
